ArticleRSC advances2018

Co-delivery of doxorubicin and shRNA of Beclin1 by folate receptor targeted pullulan-based multifunctional nanomicelles for combinational cancer therapy.

Lili Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.